BRAVYL
Live / Registered — Registered (as of 14 Feb 2023)
What this means for you
Registered since 14 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90530755
- Registration number
- 6981276
- Mark type
- Stylized text
- Filed
- 16 Feb 2021
- Published for opposition
- 19 Oct 2021
- Registered
- 14 Feb 2023
- Attorney of record
- Thomas W. MacAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system
Owner
- Woolsey Pharmaceuticals, Inx., New York, NY, US
- Woolsey Pharmaceuticals, Inx., New York, NY, US
- Woolsey Pharmaceuticals, Inx., New York, NY, US
Prosecution history
- 14 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Dec 2022 — USE AMENDMENT FILED
- 12 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2022 — SOU EXTENSION 2 GRANTED
- 05 Dec 2022 — SOU EXTENSION 2 FILED
- 05 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2022 — SOU EXTENSION 1 GRANTED
- 14 Jun 2022 — SOU EXTENSION 1 FILED
- 11 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL